GHS Confirms 10 New Mpox Cases, Total Climbs to 19
Five patients currently receiving treatment as GHS intensifies monitoring efforts
- 10 new Mpox cases confirmed, bringing total to 19
- Five patients currently hospitalized; no deaths reported
- GHS intensifies surveillance and containment efforts
Mpox, previously known as Monkeypox, continues to be monitored closely by health authorities.
Of the newly identified patients, five are currently hospitalized and receiving care. Fortunately, no fatalities have been reported in this latest outbreak.
In response, the GHS has intensified surveillance and containment efforts, particularly in regions where infections have been reported, aiming to curb further spread.
Mpox is a viral disease related to smallpox, typically marked by symptoms such as fever, intense headaches, swollen lymph nodes, muscle aches, back pain, and a distinctive skin rash. Transmission occurs through direct contact with infectious sores, bodily fluids, respiratory droplets, or contaminated objects like clothing or bedding.
The World Health Organization (WHO) has reiterated the need for enhanced funding for Mpox diagnostics, vaccines, and public education across Africa.
It also underscored the importance of combatting stigma, encouraging those affected to seek medical care promptly and without fear of discrimination.
